COL10A1+Fib was predominantly localized to tumor tissues, with its abundance and expression level significantly higher in tumors than in normal tissues across all cancers except prostate cancer (Figs. 10J–L, Supplementary Fig. 15E). This evidence concerns the gene FBL and prostate carcinoma.